5/5/2014 7:22:05 AM
The FDA put their highest-risk warning on a recall of infusion pumps by Hospira (NYSE:HSP) and Abbott (NYSE:ABT), saying that a broken door assembly may cause an over- or under-infusion of drug therapy. The FDA noted that Hospira had received customer complaints about the Abbott Acclaim infusion pumps and the Hospira Acclaim Encore infusion pumps. The devices are used to deliver a range of therapies, including whole blood, medicines and nutritional fluids.
Help employers find you! Check out all the jobs and post your resume.
comments powered by